Download:
pdf |
pdfFeedback: 13th Annual NIH SBIR/STTR Conference, June 22-23, 2011
OMB CLEARANCE INFORMATION
Form Approved
OMB# 09250627
Expiration Date: 02/28/2014
According to the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB
control number. The valid OMB control number of this information collection is 09250627. The time required to complete this information
collection is estimated to average 10 minutes per response, including the time to review instructions, search existing data resources, gather the
data needed, and complete and review the information collection. If you have any comments concerning the accuracy of the time estimate(s) or
suggestions for improving this form, please write to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 208927974
Attn: PRA (Seleda Perryman). If you have comments or concerns regarding the status of your individual submission of this form, contact: Ripple
Effect Communications, Inc. NIH, OER, OER 6705 Rockledge Drive, Suite 310 Bethesda, Maryland 208927980. 18002775708. Attn: Janelle
Jobe.
(Note to OMB Desk Officer: This will be an online form.)
GENERAL ATTENDEE INFORMATION
Your input about this conference is very important. Thank you for your time. Your programmatic and administrative
suggestions will be used to improve future events.
*Please note that required questions have an asterisk.*
What was your purpose for attending the NIH SBIR/STTR conference?
5
6
*Have you previously submitted an SBIR or STTR application to NIH?
j Yes
k
l
m
n
j No
k
l
m
n
j N/A
k
l
m
n
Were you funded?
j Yes
k
l
m
n
j No
k
l
m
n
j N/A
k
l
m
n
Page 1
Feedback: 13th Annual NIH SBIR/STTR Conference, June 22-23, 2011
Is/Was the NIH SBIR/ STTR funded grant new or a renewal?
j New
k
l
m
n
j Renewal
k
l
m
n
DAY 1 SESSIONS, SUBMISSION, POLICIES, PROCEDURES
Indicate the effectiveness of Wednesday's sessions.
Helpful
Not Helpful
N/A
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Overview NIH SBIR/STTR Program
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
NIH SBIR/STTR Receipt and Referral Processes
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
NIH SBIR/STTR Review Process
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Preparing A Successful Application
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Post Award Compliance for SBIR/STTR Grantees
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
NIH Resources for Small Business Success
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Successfully Submitting Your Grant Application
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Identifying NIH SBIR/STTR Funding Opportunities
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Facilitating Translation Through Collaborations
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Indirect Cost Rates & Accounting Systems
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Research Involving Human Subjects
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Research Involving Animals
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Products, Partners & Public Health
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
A Look Into the NIH ICs(NCI, NIAID, NHLBI)
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
WrapUp:Day One
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Catalyzing Innovation:NIH National Center for Advancing Translational
Sciences
Comments
5
6
DAY 2 SESSIONS, TRANSITIONING TO THE MARKETPLACE
Page 2
Feedback: 13th Annual NIH SBIR/STTR Conference, June 22-23, 2011
Indicate the effectiveness of Thursday's sessions.
Helpful
Not Helpful
N/A
Strategies for Commercialization
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Indirect Cost Rates and Accounting Systems
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Successfully Submitting Your Grant Application
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Raising Followon Capital
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
A Look Into NIH ICs(NINDS, NIMHD, NCCAM)
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Building Corporate Alliances & Partnerships
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Commercialization of Behavioral Services, Interventions & Products
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
A Look Into NIH ICs(NIA, NIAMS, NIGMS)
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Protecting Intellectual Property
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Commercializing Healthcare/IT/Media Product
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
A Look Into NIH ICs (NIMH, NIDA, NIEHS)
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Regulatory Requirements: Medical Devices
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Leveraging State Resources
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Regulatory Requirements: Pharmaceuticals
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
NIH Technical Assistance Programs
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Moving from R&D to Manufacturing: NIST Program
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
A Look Into the CDC
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Comments
5
6
OVERALL PROGRAM FEEDBACK
Were the OneonOne discussions with NIH/CDC/FDA Staff helpful?
j Yes
k
l
m
n
j No
k
l
m
n
j N/A I did not participate
k
l
m
n
Comment
5
6
Page 3
Feedback: 13th Annual NIH SBIR/STTR Conference, June 22-23, 2011
Was NIH staff helpful in responding to your questions?
j Yes
k
l
m
n
j No
k
l
m
n
Comments
5
6
*As a result of this conference, are you more confident of your ability to prepare a
competitive SBIR/STTR grant application?
j Yes
k
l
m
n
j No
k
l
m
n
j N/A
k
l
m
n
Comments
5
6
*Did the conference meet your expectations?
j Yes
k
l
m
n
j No
k
l
m
n
If not, why?
5
6
Page 4
Feedback: 13th Annual NIH SBIR/STTR Conference, June 22-23, 2011
*What is your overall rating of this conference?
j Excellent
k
l
m
n
j Good
k
l
m
n
j Fair
k
l
m
n
j Poor
k
l
m
n
Overall Comments
5
6
POST CONFERENCE WORKSHOP: NAT'L INNOVATION MARKETPLACE
The following questions are regarding the post conference National Innovation Marketplace workshop.
Did you attend the post conference workshop “National Innovation Marketplace?”
j Yes
k
l
m
n
j No
k
l
m
n
Did the workshop help you develop a marketing description of your SBIR/STTR
developed technology in layman’s terms?
j Yes
k
l
m
n
j No
k
l
m
n
Page 5
Feedback: 13th Annual NIH SBIR/STTR Conference, June 22-23, 2011
Do you intend to take the next step and submit the needed information to produce a
Merwyn Business Simulation report for inclusion in the NIST MEP USA National
Innovation Marketplace?
j Yes
k
l
m
n
j No
k
l
m
n
Please explain why not:
5
6
General Comments about the Post Conference Workshop:
5
6
FUTURE & SERVICE OFFERINGS
Please give some thought to the following questions to help us identify areas of success and areas for improvement. We
appreciate your time and reflections.
What new topics would be of interest to you at future NIH SBIR/STTR Conferences?
5
6
For this year’s event, how satisfied were you with the:
Extremely
Very
Somewhat
Not At All
Attendee Materials
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Advance Registration
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Onsite Registration Process
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Food and Beverage
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
Process
Provided
Meeting Facility
Comments
5
6
Page 6
Feedback: 13th Annual NIH SBIR/STTR Conference, June 22-23, 2011
How did you first learn about this year's NIH SBIR/STTR Conference?
j A Colleague
k
l
m
n
j NIH SBIR/STTR Website
k
l
m
n
j NIH Institute/Center Program Office or Grants Manager
k
l
m
n
j Internet Search Engine
k
l
m
n
j Professional Society
k
l
m
n
j NIH ListServ
k
l
m
n
Other (please specify)
Are you a decision maker for your organization?
j Yes
k
l
m
n
j No
k
l
m
n
Is this your first time attending the NIH SBIR/STTR Conference?
j Yes
k
l
m
n
j No
k
l
m
n
How long ago did you attend your last NIH SBIR/STTR Conference?
j Last year
k
l
m
n
j 25 years
k
l
m
n
j 610 years
k
l
m
n
j 10+ years
k
l
m
n
Page 7
Feedback: 13th Annual NIH SBIR/STTR Conference, June 22-23, 2011
*Please select ONLY one (1) area of interest:
j AgBio, Environmental
k
l
m
n
j Behavioral and Social, Mental Health, Drug & Alcohol Abuse, Neurology
k
l
m
n
j Bioinformatics, Proteomics, Genomics, Research Tools
k
l
m
n
j Biomaterials, Biosensors, Blood Products, Implanted Devices, Surgery
k
l
m
n
j Complementary and Alternative Medicine
k
l
m
n
j Diagnostics (in vitro and in vivo), Imaging
k
l
m
n
j Drug Discovery, Drug Development, Drug Delivery, Biopharmaceuticals
k
l
m
n
j Medical Informatics, Medical Infrastructure, Patient/physician Education
k
l
m
n
j Rehabilitation, Externally Worn Devices, Patient Bedside care
k
l
m
n
j SBIR/STTR Support Organization
k
l
m
n
General Comments about the Conference:
5
6
Page 8
| File Type | application/pdf |
| File Modified | 0000-00-00 |
| File Created | 0000-00-00 |